Recently, the European Prospective Investigation into Cancer and Nutrition (EPIC) study found no association between pre-diagnostic circulating resistin concentrations and the risk of CRC, suggesting the role of resistin as a possible marker of CRC instead of a risk factor [41]. This evidence concerns the gene RETN and cancer.